{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:17:09Z","timestamp":1714987029281},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00108-006-1583-1","type":"journal-article","created":{"date-parts":[[2006,2,9]],"date-time":"2006-02-09T14:46:06Z","timestamp":1139496366000},"page":"252-265","source":"Crossref","is-referenced-by-count":6,"title":["Folgeerkrankungen nach Organtransplantation"],"prefix":"10.1007","volume":"47","author":[{"given":"S.","family":"Ciesek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1583_CR1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(04)16148-5","volume":"363","author":"Aharinejad","year":"2004","unstructured":"Aharinejad S, Taghavi S, Klepetko W, Abraham D (2004) Prediction of lung-transplant rejection by hepatocyte growth factor. Lancet 363: 1503\u20131508","journal-title":"Lancet"},{"key":"1583_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003495-200363040-00003","volume":"63","author":"Asberg","year":"2003","unstructured":"Asberg A (2003) Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients. Drugs 63: 367\u2013378","journal-title":"Drugs"},{"key":"1583_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2005.01.011","volume":"42","author":"Berenguer","year":"2005","unstructured":"Berenguer M (2005) What determines the natural history of recurrent hepatitis C after liver transplantation? J Hepatol 42: 448\u2013456","journal-title":"J Hepatol"},{"key":"1583_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.trim.2005.03.022","volume":"14","author":"Bradley","year":"2005","unstructured":"Bradley BA (2005) Prognostic assays for rejection and tolerance in organ transplantation. Transpl Immunol 14: 193\u2013201","journal-title":"Transpl Immunol"},{"key":"1583_CR5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04083","volume":"436","author":"Brown","year":"2005","unstructured":"Brown RS (2005) Hepatitis C and liver transplantation. Nature 436: 973\u2013978","journal-title":"Nature"},{"key":"1583_CR6","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","volume":"80","author":"Buell","year":"2005","unstructured":"Buell JF, Gross TG, Woodle ES (2005) Malignancy after transplantation. Transplantation 80: S254\u2013264","journal-title":"Transplantation"},{"key":"1583_CR7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1053\/jlts.2003.50105","volume":"9","author":"Busuttil","year":"2003","unstructured":"Busuttil RW, Tanaka K (2003) The utility of marginal donors in liver transplantation. Liver Transpl 9: 651\u2013663","journal-title":"Liver Transpl"},{"key":"1583_CR8","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","volume":"19","author":"Cohen","year":"2004","unstructured":"Cohen A, Sambrook P, Shane E (2004) Management of bone loss after organ transplantation. J Bone Miner Res 19: 1919\u20131932","journal-title":"J Bone Miner Res"},{"key":"1583_CR9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/diacare.27.3.805","volume":"27","author":"Davidson","year":"2004","unstructured":"Davidson JA, Wilkinson A, International Expert Panel on New-Onset Diabetes after Transplantation (2004) New-Onset Diabetes after Transplantation 2003 International Consensus Guidelines: an endocrinologist\u2019s view. Diabetes Care 27: 805\u2013812","journal-title":"Diabetes Care"},{"key":"1583_CR10","unstructured":"DSO (2004) Statistik der deutschen Stiftung Organtransplantation. http:\/\/www.dso.de"},{"key":"1583_CR11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","volume":"338","author":"Fishman","year":"1998","unstructured":"Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338: 1741\u20131751","journal-title":"N Engl J Med"},{"key":"1583_CR12","first-page":"167","volume":"67","author":"Guild","year":"1955","unstructured":"Guild WR, Harrison JH, Merrill JP, Murray J (1955\u20131956) Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc 67: 167\u2013173","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"1583_CR13","first-page":"31","volume":"6","author":"Hausberg","year":"2001","unstructured":"Hausberg M, Kosch M, Hohage H, Suwelack B, Barenbrock M, Kisters K, Rahn KH (2001) Antihypertensive treatment in renal transplant patients \u2014 is there a role for ACE inhibitors? Ann Transplant 6: 31\u201337","journal-title":"Ann Transplant"},{"key":"1583_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1634\/theoncologist.10-4-269","volume":"10","author":"Hertl","year":"2005","unstructured":"Hertl M, Benedict Cosimi A (2005) Liver transplantation for malignancy. Oncologist 10: 269\u2013281","journal-title":"Oncologist"},{"key":"1583_CR15","first-page":"258","volume":"44","author":"Hintze","year":"1997","unstructured":"Hintze RE, Adler A, Veltzke W, Abou-Rebyeh H, Felix R, Neuhaus P (1997) Endoscopic management of biliary complications after orthotopic liver transplantation. Hepatogastroenterology 44: 258\u2013262","journal-title":"Hepatogastroenterology"},{"key":"1583_CR16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1365-2168.2002.02165.x","volume":"89","author":"Janssen","year":"2002","unstructured":"Janssen H, Lange R, Erhard J, Malago M, Eigler FW, Broelsch CE (2002) Causative factors, surgical treatment and outcome of incisional hernia after liver transplantation. Br J Surg 89: 1049\u20131054","journal-title":"Br J Surg"},{"key":"1583_CR17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1053\/j.ajkd.2004.01.018","volume":"43","author":"Jindal","year":"2004","unstructured":"Jindal RM, Zawada ET (2004) Obesity and kidney transplantation. Am J Kidney Dis 43: 943\u2013952","journal-title":"Am J Kidney Dis"},{"key":"1583_CR18","first-page":"S32","volume":"17","author":"Kahan","year":"2004","unstructured":"Kahan BD (2004) Sirolimus-based immunosuppression: present state of the art. J Nephrol 17 [Suppl 8]: S32\u201339","journal-title":"J Nephrol"},{"key":"1583_CR19","first-page":"S99","volume":"27","author":"Kreis","year":"2001","unstructured":"Kreis H (2001) New strategies to reduce nephrotoxicity. Transplantation 27: S99\u2013104","journal-title":"Transplantation"},{"key":"1583_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1034\/j.1399-0012.2003.00119.x","volume":"17","author":"Lopez-Navidad","year":"2003","unstructured":"Lopez-Navidad A, Caballero F (2003) Extended criteria for organ acceptance: Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 17: 308\u2013324","journal-title":"Clin Transplant"},{"key":"1583_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","volume":"357","author":"Leidig-Bruckner","year":"2001","unstructured":"Leidig-Bruckner G, Hosch S, Dodidou P et al. (2001) Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357: 342\u2013347","journal-title":"Lancet"},{"key":"1583_CR22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2004-1978","volume":"90","author":"Maalouf","year":"2005","unstructured":"Maalouf NM, Shane E (2005) Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab 90: 2456\u20132465","journal-title":"J Clin Endocrinol Metab"},{"key":"1583_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1600-6143.2003.00366.x","volume":"4","author":"Opelz","year":"2004","unstructured":"Opelz G, Dohler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4: 153\u2013154","journal-title":"Am J Transplant"},{"key":"1583_CR24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/36.7.808","volume":"36","author":"Panayi","year":"1997","unstructured":"Panayi GS, Tugwell P (1997) The use of cyclosporin A microemulsion in rheumatoid arthritis: conclusions of an international review. Br J Rheumatol 36: 808\u2013811","journal-title":"Br J Rheumatol"},{"key":"1583_CR25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11892-005-0027-y","volume":"5","author":"Pavlakis","year":"2005","unstructured":"Pavlakis M (2005) New-onset diabetes after transplantation. Curr Diab Rep 5: 300\u2013304","journal-title":"Curr Diab Rep"},{"key":"1583_CR26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0168-8278(01)00089-7","volume":"34","author":"Rosenau","year":"2001","unstructured":"Rosenau J, Bahr MJ, Tillmann HL, Trautwein C, Klempnauer J, Manns MP, Boker KHW (2001) Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection. J Hepatol 34: 895\u2013902","journal-title":"J Hepatol"},{"key":"1583_CR27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.TP.0000148239.00384.F0","volume":"79","author":"Rowshani","year":"2005","unstructured":"Rowshani AT, Bemelman FJ, van Leeuwen EM, van Lier RA, ten Berge IJ (2005) Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation 79: 381\u2013386","journal-title":"Transplantation"},{"key":"1583_CR28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-3468(99)90385-8","volume":"34","author":"Ryckman","year":"1999","unstructured":"Ryckman FC, Alonso MH, Bucuvalas JC, Balistreri WF (1999) Long-term survival after liver transplantation. J Pediatr Surg 34: 845\u2013849","journal-title":"J Pediatr Surg"},{"key":"1583_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2004-828679","volume":"24","author":"Samuel","year":"2004","unstructured":"Samuel D (2004) Management of hepatitis B in liver transplantation patients. Semin Liver Dis 24 [Suppl 1]: 55\u201362","journal-title":"Semin Liver Dis"},{"key":"1583_CR30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/bega.2000.0105","volume":"14","author":"Strassburg","year":"2000","unstructured":"Strassburg CP, Manns MP (2000) Autoantibodie tests in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 14: 585\u2013599","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"1583_CR31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00108-003-1127-x","volume":"45","author":"Strassburg","year":"2004","unstructured":"Strassburg CP, Manns MP (2004) Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy. Internist 45: 16\u201326","journal-title":"Internist"},{"key":"1583_CR32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00108-004-1295-3","volume":"45","author":"Strassburg","year":"2004","unstructured":"Strassburg CP, Becker T, Klempnauer J, Manns MP (2004) Liver transplantation: deciding between need and donor allocation. Internist 45: 1233\u20131245","journal-title":"Internist"},{"key":"1583_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000016918","volume":"17","author":"Tung","year":"1999","unstructured":"Tung BY, Kimmey MB (1999) Biliary complications of orthotopic liver transplantation. Dig Dis 17: 133\u2013144","journal-title":"Dig Dis"},{"key":"1583_CR34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000441-200304000-00006","volume":"325","author":"Zhang","year":"2003","unstructured":"Zhang R, Leslie B, Boudreaux JP, Frey D, Reisin E (2003) Hypertension after kidney transplantation: impact, pathogenesis and therapy. Am J Med Sci 325: 202\u2013208","journal-title":"Am J Med Sci"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-006-1583-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1583-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:35Z","timestamp":1558584695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-006-1583-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1007\/s00108-006-1583-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}